title: Treating advanced cardiac damage in light chain amyloidosis: still an unmet need.
authors.affiliation: Amyloidosis Research and Treatment Center, Scientific Institute Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Italy gmerlini@unipv.it.
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Merlini
authors.affiliation: Amyloidosis Research and Treatment Center, Scientific Institute Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Palladini
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D009202:Cardiomyopathies / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000075363:Immunoglobulin Light-chain Amyloidosis; D008297:Male; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide